High-quality scientific research on cancer is very important. Studying the basic biology of cancer is one of the major challenges in cancer research. Work will be initiated in the areas of cancer stem cells, signal transduction pathways, oncogenic role of metabolites, non-coding RNAs and epigenetic modulators. Studies on the role of repurposed drugs as pathway inhibitors for new/existing mutations will be initiated. Research will also be directed towards developing cell lines from Indian patients and Patient derived xenografts (PDX).